Evaluation of Insulin Like Growth Facror-1 Genetic Polymorphism with Gastric Cancer Susceptibility and Clinicopathological Features |
Farahani, Roya Kishani
(Basic and Molecular Epidemiology of Gastroenterology, Disease Research Center, Shahid Beheshti University of Medical Sciences)
Azimzadeh, Pedram (Basic and Molecular Epidemiology of Gastroenterology, Disease Research Center, Shahid Beheshti University of Medical Sciences) Rostami, Elham (Basic and Molecular Epidemiology of Gastroenterology, Disease Research Center, Shahid Beheshti University of Medical Sciences) Malekpour, Habib (Gastroenterology and Liver, Disease Research Center, Shahid Beheshti University of Medical Sciences) Aghdae, Hamid Asadzadeh (Basic and Molecular Epidemiology of Gastroenterology, Disease Research Center, Shahid Beheshti University of Medical Sciences) Pourhoseingholi, Mohamad Amin (Gastroenterology and Liver, Disease Research Center, Shahid Beheshti University of Medical Sciences) Mojarad, Ehsan Nazemalhosseini (Gastroenterology and Liver, Disease Research Center, Shahid Beheshti University of Medical Sciences) Zali, Mohammad Reza (Gastroenterology and Liver, Disease Research Center, Shahid Beheshti University of Medical Sciences) |
1 | Altinkaynak K, Bilici M, Bakan N, Akcay F (2012). Circulating levels of IGF-I and IGFBP-3 in gastric cancer. Turk J Med Sci, 42, 1458-62. |
2 | Arkani M, Safaei A, Karimi Kh, Mohsen Vahedi, et al (2012). Association of IGF-1 gene (rs5742612) polymorphism with colorectal cancer. J Sabzevar Univers Med Sc, 19, 109-15. |
3 | Altinkaynak K, Bilici M, Bakan N, Akay F (2012). Circulating levels of IGF-I and IGFBP-3 in gastric cancer. Turk J Med Sci, 42, 1458-62. |
4 | Chan JM, Stampfer MJ, Ma J, et al (2002). Insulin-like growth factor-I (IGF-I) and IGF binding protein-3 as predictors of advanced-stage prostate cancer. J Natl Cancer Inst, 94, 1099-106. DOI |
5 | Cheng I, Stram DO, Penney KL, et al (2006). Common genetic variation in IGF1 and prostate cancer risk in the multiethnic cohort. J Natl Cancer Inst, 98 ,123-34. DOI |
6 | Chen W, Wang S, Tian T, et al (2009). Phenotypes and genotypes of insulin-like growth factor 1, IGF-binding protein-3 and cancer risk: evidence from 96 studies. European J Human Genet, 17, 1668-75. DOI |
7 | Delafontaine P, Song Y, Li Y (2004). Expression, Regulation, and Function of IGF-1, IGF-1R, and IGF-1 Binding Proteins in Blood Vessels. Arterioscler Thromb Vasc Biol, 24, 435-44. DOI |
8 | D'Aloisio AA, JC Schroeder, Kari E, et al (2009). IGF-I and IGFBP-3 polymorphisms in relation to circulating levels among African American and Caucasian women. Cancer Epidemiol Biomarkers Prev, 18, 954-66. DOI |
9 | Feik E, Baierl A, Hieger B, et al (2010). Association of IGF1 and IGFBP3 polymorphisms with colorectal polyps and colorectal cancer risk. Cancer Causes Control, 21, 91-7. DOI |
10 | Forman D, Burley V (2006). Gastric cancer: global pattern of the disease and an overview of environmental risk factors. Best Pract Res Clin Gastroenterol, 20, 633-49. DOI |
11 | Furstenberger G, Senn HJ (2002). Insulin-like growth factors and cancer. Lancet Oncol, 3, 298-302. DOI |
12 | Gao L, Nieters A, Brenner H (2009). Cell proliferation-related genetic polymorphisms and gastric cancer risk: systematic review and meta-analysis. European J Human Genet, 17, 1658-67. DOI ScienceOn |
13 | Harrela M, Koistinen H, Kaprio J, et al (1996) Genetic and environmental components of interindividual variation in circulating levels of IGF-1, IGF-II, IGFBP-3. J Clin Invest, 98, 2612-15. DOI |
14 | Karamouzis MV, Papavassiliou AG (2006). The IGF-1 network in lung carcinoma therapeutics. Trends Mol Med, 12, 595-602. DOI |
15 | Katoh T, Nagata N, Kuroda Y, et al (1996). Glutathione S-transferase M1(GSTM1) and T1 (GSTT1) genetic polymorphism and susceptibility to gastric and colorectal adenocarcinoma. Carcinogenesis, 17, 1855-9. DOI |
16 | Lukanova A, Lundin E, Toniolo P, et al (2002). Circulating levels of insulin-like growth factor-I and risk of ovarian cancer. Int J Cancer, 101, 549-54. DOI |
17 | Lukanova A, Lundin E, Micheli A, et al (2003). Risk of ovarian cancer in relation to prediagnostic levels of C-peptide, insulinlike growth factor binding proteins-1 and -2 (USA, Sweden, Italy). Cancer Causes Control, 14, 285-92. DOI |
18 | Lacey JV, Potischman N, Madigan MP, et al (2004). Insulin-like growth factors, insulin-like growth factor-binding proteins, and endometrial cancer in postmenopausal women: results from a US case-control study. Cancer Epidemiol Biomarkers Prev, 13, 607-12. |
19 | McLean MH, El-Omar EM (2014). Genetics of gastric cancer. Nature Rev Gastroenterol Hepatol, 11, 664-74. DOI |
20 | Lian H, Zhou Y, Jian Z, Liu R (2014). MiR-323-5p acts as a tumor suppressor by targeting the insulin-like growth factor 1 receptor in human glioma cells. Asian Pac J Cancer Prev, 15, 10181-85. |
21 | Malekzadeh R, Derakhshan MH, Malekzadeh Z (2009). Gastric cancer in Iran: epidemiology and risk factors. Arch Iran Med, 12, 576-83. |
22 | Miller S, Dykes D, Polesky H (1988). A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res, 16, 1215. DOI |
23 | Ma J, Pollak MN, Giovannucci E, et al (1999). Prospective study of colorectal cancer risk in men and plasma levels of insulinlike growth factor (IGF)-I and IGFbinding protein-3. J Natl Cancer Inst, 91, 620-5. DOI |
24 | Nakao M, Hosono S , Ito H , et al (2011). Interaction between IGF-1 polymorphisms and overweight for the risk of pancreatic cancer in Japanese. Int J Mol Epidemiol Genet, 2, 354-66. |
25 | Pollak M (2008). Insulin and insulin-like growth factor signalling in neoplasia. Nat Rev Cancer, 8, 915-28. DOI |
26 | Qian J, Zhou H, Chen J, et al (2014). Genetic polymorphisms in IGF-I and IGFBP-3 are associated with prostate cancer in the Chinese population. Plos one, 9, 85609-15. DOI |
27 | Rostami M, Kadivar M, Aznab M, Abachi M (2011). Influence of age and gender on association between-765G> C COX-2 genetic polymorphism and gastric adenocarcinoma risk: a case-control study in Iran. Gastroenterol Hepatol Bed Bench, 5, 29-3. |
28 | Smith MG, Hold GL, Tahara E, El-Omar EM (2006). Cellular and molecular aspects of gastric cancer. World J Gastroenterol, 12, 2979-90. DOI |
29 | Stadtlander CTH (1999). Molecular epidemiology, pathogenesis and prevention of gastric cancer. Carcinogenesis, 20, 2195-208. DOI |
30 | Setiawan VW, Zhang ZF, Yu GP, et al (2000). GSTT1 and GSTM1 null genotypes and the risk of gastric cancer: a case-control study in a Chinese population. Cancer Epidemiol Biomarkers Prev, 9, 73-80. |
31 | Samani AA, Yakar S, LeRoith D, et al (2007). The role of the IGF system in cancer growth and metastasis: overview and recent insights. Endocr Rev, 28, 20-47. DOI |
32 | Shitara K, Ito S, Misawa K, et al (2011). Genetic polymorphism of IGF-I predicts recurrence in patients with gastric cancer who have undergone curative gastrectomy. Ann Oncol, 23, 659-64. |
33 | Setiawan VW, Cheng I, Stram DO, et al (2006). Igf-I genetic variation and breast cancer: the multiethnic cohort. Cancer Epidemiol Biomarkers Prev, 15, 172-4. DOI |
34 | Tong D, Wen X, Jin Y, et al (2010). Changes of androgen receptor and insulin-like growth factor-1 in LNCaP prostate cancer cells treated with sex hormones and flutamide. Asian Pac J Cancer Prev, 11, 1805-9. |
35 | Tsugane S, Inoue M (2010). Insulin resistance and cancer: epidemiological evidence. Cancer Sci, 101, 1073-79. DOI |
36 | Tao Y, Pinzi V, Bourhis J, Deutsch E (2007). Mechanisms of disease: signaling of the insulin-like growth factor 1 receptor pathway-therapeutic perspectives in cancer. Nat Clin Pract Oncol, 4, 591-602. |
37 | Wong HL, Delellis K, Probst-Hensch N, et al (2005). A new single nucleotide polymorphism in the insulin-like growth factor I regulatory region associates with colorectal cancer risk in Singapore chinese. Cancer Epidemiol Biomarkers Prev, 14, 144-51. |
38 | Yang H, Qu R, Lin X , et al (2014). IGF-1 from adipose-derived mesenchymal stem cells promoes radioresistance of breast cancer cells. Asian Pac J Cancer Prev, 15, 10115-9. |
39 | Wolk A, Mantzoros CS, Andersson SO, et al (1998). Insulin-like growth factor 1 and prostate cancer risk: a population-based, case-control study. J Natl Cancer Inst, 90, 911-5. DOI |
40 | Yu H, Rohan T (2000). Role of the insulin-like growth factor family in cancer development and progression. J Natl Cancer Inst J, 92, 1472-89. DOI |